Ligand Pharmaceuticals
LGND
#3601
Rank
ยฃ2.73 B
Marketcap
ยฃ138.77
Share price
-1.93%
Change (1 day)
43.36%
Change (1 year)

Ligand Pharmaceuticals (LGND) - Cash on Hand

Cash on Hand as of September 2025 : ยฃ0.50 Billion

According to Ligand Pharmaceuticals's latest financial reports the company has ยฃ0.50 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Ligand Pharmaceuticals - Cash on Hand chart (from 1996 to 2025)

Cash on Hand by year

Year Cash on Hand Change
2024-12-31ยฃ0.20 B52.7%
2023-12-31ยฃ0.13 B-23.67%
2022-12-31ยฃ0.17 B-30.7%
2021-12-31ยฃ0.25 B-16.23%
2020-12-31ยฃ0.30 B-63.03%
2019-12-31ยฃ0.81 B33.83%
2018-12-31ยฃ0.60 B308.56%
2017-12-31ยฃ0.14 B30.53%
2016-12-31ยฃ0.11 B-15.39%
2015-12-31ยฃ0.13 B25.71%
2014-12-31ยฃ0.10 B1009.51%
2013-12-31ยฃ9.68 M26.46%
2012-12-31ยฃ7.66 M-30.13%
2011-12-31ยฃ10.96 M-25.43%
2010-12-31ยฃ14.7 M-55.3%
2009-12-31ยฃ32.89 M-40.24%
2008-12-31ยฃ55.04 M15.83%
2007-12-31ยฃ47.52 M-45.83%
2006-12-31ยฃ87.73 M74.04%
2005-12-31ยฃ50.41 M-13.97%
2004-12-31ยฃ58.59 M5.84%
2003-12-31ยฃ55.36 M38.17%
2002-12-31ยฃ40.06 M54.15%
2001-12-31ยฃ25.99 M63.95%
2000-12-31ยฃ15.85 M-45.72%
1999-12-31ยฃ29.21 M48.09%
1998-12-31ยฃ19.72 M-47.99%
1997-12-31ยฃ37.92 M86.61%
1996-12-31ยฃ20.32 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
Amgen
AMGN
ยฃ7.08 B 1,295.25%๐Ÿ‡บ๐Ÿ‡ธ USA
Spectrum Pharmaceuticals
SPPI
ยฃ42.13 M-91.71%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
ยฃ3.33 B 556.54%๐Ÿ‡ฌ๐Ÿ‡ง UK
Merck
MRK
ยฃ13.67 B 2,590.65%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
ยฃ11.24 B 2,113.50%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
ยฃ7.44 B 1,364.46%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
ยฃ12.38 B 2,337.74%๐Ÿ‡บ๐Ÿ‡ธ USA
Baxter
BAX
ยฃ1.29 B 154.97%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
ยฃ13.93 B 2,642.05%๐Ÿ‡บ๐Ÿ‡ธ USA